Inflammation, Mutations Impact Colorectal Cancer Immunotherapy Response
In a groundbreaking study published in Nature Communications, researchers uncover how the interplay between inflammation and mutational burden distinctly influences ...
In a groundbreaking study published in Nature Communications, researchers uncover how the interplay between inflammation and mutational burden distinctly influences ...
(Barcelona, Spain – September 8, 2025, 10:45 a.m. CEST / UTC +2) — In a pivotal development presented at the ...
In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking real-world study published in BMC Cancer, researchers have unveiled compelling evidence supporting the survival benefits of combining ...
In the rapidly evolving field of oncology, one of the most perplexing challenges remains the management of cancer of unknown ...
In recent years, the landscape of oncology has undergone a transformative evolution, particularly in the treatment of rectal cancer. Traditional ...
In recent years, immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering new hope to patients with various malignancies. These ...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, opening new horizons in the fight against malignancies by unleashing the immune ...
Immune checkpoint inhibitors (ICIs) have revolutionized oncology, marking a profound leap forward in cancer immunotherapy. By targeting and blocking inhibitory ...
In the rapidly evolving landscape of cancer immunotherapy, recent groundbreaking research delves into an underexplored yet pivotal component of the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine